It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2010.
2010 | Hyderabad, Telangana, India | ActiveAptus Therapeutics Private Limited, a active private limited company, was established on 16 December 2010 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the manufacturing sector, it holds CIN: U24232TG2010PTC071724. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹0.30 M.
It upholds a compliant status. Employing 9 professional, Its leadership includes Sirisha Tiyyagura (Director), Koti Reddy Tiyyagura (Director). Past directors included Praveen Bommu, Venkata Lakshmi Konda, Harinadh Reddy Pamulapati. Its latest AGM occurred on 03 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.105, Road No.8 Aleap Industrial Area Pragathinagar, Kukatpally, Hyderabad, Telangana, 500090.
U24232TG2010PTC071724
071724
16 December 2010
₹1.00 Cr
₹0.30 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Aptus Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sirisha Tiyyagura | Director | 29 Jul 2023 | Current |
| Koti Reddy Tiyyagura | Director | 16 Dec 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 26 Dec 2016 | Past |
| Pramod Abcsdd | Director | 01 Mar 2021 | Past |
| Pramod Abcsdd | Additional Director | 29 Jul 2023 | Past |
| Pramod Abcsdd | Director | 07 Jul 2022 | Past |
| Pramod Abcsdd | Director | 01 Mar 2021 | Past |
| Pramod Abcsdd | Director | 26 Dec 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aptus Therapeutics Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 92.72% decrease. The company also saw a substantial fall in profitability, with a 146.77% decrease in profit. The company's net worth observed a substantial decline by a decrease of 29.58%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Aptus Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Aptus Therapeutics has a workforce of 9 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aptus Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aptus Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Aptus Therapeutics Private Limited last Annual general meeting of members was held on 03 Sep 2024 as per latest MCA records. was documented.
Aptus Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
The activity Sirisha Tiyyagura was appointed as a Director was appointed as a Director on 29 Jul 2023 & has been associated with this company since 2 years 4 months . was completed.
Progress on Koti Reddy Tiyyagura was appointed as a Director was appointed as a Director on 16 Dec 2010 & has been associated with this company since 14 years 11 months . was documented.
The activity Aptus Therapeutics Private Limited was registered on 16 Dec 2010 with Roc Hyderabad & aged 14 years 11 months as per MCA records. was completed.
The CIN of Aptus Therapeutics Private Limited is U24232TG2010PTC071724.
Aptus Therapeutics Private Limited is headquartered at Plot No.105, Road No.8 Aleap Industrial Area Pragathinagar, Kukatpally, Hyderabad, Telangana, 500090.
Aptus Therapeutics Private Limited was incorporated on 16 December 2010.
The current directors of Aptus Therapeutics Private Limited are
The primary industry of Aptus Therapeutics Private Limited is Manufacturing.
Aptus Therapeutics Private Limited is unlisted.
The authorized capital of Aptus Therapeutics Private Limited is ₹1.00 Cr, and the paid-up capital is ₹0.30 M.
The compliance status of Aptus Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX